Chemoinformaics analysis of TANAPARTHIN-BETA-PEROXIDE
| Molecular Weight | 278.304 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 20 |
| Exact Molecular Weight | 278.115 | nRing | 4 |
| Solubility: LogS | -2.937 | nHRing | 2 |
| Solubility: LogP | 1.435 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 41.0623 |
| nHD | 1 | BPOL | 22.3977 |
| QED | 0.313 |
| Synth | 5.854 |
| Natural Product Likeliness | 3.539 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.083 |
| Pgp-sub | 0 |
| HIA | 0.071 |
| CACO-2 | -4.823 |
| MDCK | 0.000026 |
| BBB | 0.847 |
| PPB | 0.577991 |
| VDSS | 1.05 |
| FU | 0.457282 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.888 |
| CYP2c19-inh | 0.117 |
| CYP2c19-sub | 0.84 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.088 |
| CYP2d6-inh | 0.125 |
| CYP2d6-sub | 0.376 |
| CYP3a4-inh | 0.565 |
| CYP3a4-sub | 0.642 |
| CL | 6.1 |
| T12 | 0.244 |
| hERG | 0.034 |
| Ames | 0.077 |
| ROA | 0.987 |
| SkinSen | 0.088 |
| Carcinogencity | 0.948 |
| EI | 0.017 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.914 |
| Antiviral | Yes |
| Prediction | 0.795308 |